Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

[1]  C Marcelli,et al.  Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  W. Dmowski,et al.  Urinary N‐Telopeptides to Monitor Bone Resorption While on GnRH Agonist Therapy , 1996, Obstetrics and gynecology.

[3]  C. Chesnut.  Medical Treatment Of Osteoporosis , 1995 .

[4]  H. Genant,et al.  Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. , 1995, The American journal of medicine.

[5]  P. Delmas,et al.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. , 1994, The Journal of clinical endocrinology and metabolism.

[6]  P. Delmas,et al.  The short-term effects of conjugated estrogen on bone turnover in older women. , 1994, The Journal of clinical endocrinology and metabolism.

[7]  H. Genant,et al.  Monitoring bone resorption in early postmenopausal women by an immunoassay for cross‐linked collagen peptides in urine , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  W. O'Fallon,et al.  Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  J. Wergedal,et al.  Reference standards for quantification of skeletal alkaline phosphatase activity in serum by heat inactivation and lectin precipitation. , 1993, Clinical chemistry.

[10]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.

[11]  D. Eyre,et al.  A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  L. Melton,et al.  The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.

[13]  A. Lane,et al.  Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.

[14]  H K Genant,et al.  Axial and appendicular bone density predict fractures in older women , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  D. Eyre.  New biomarkers of bone resorption. , 1992, The Journal of clinical endocrinology and metabolism.

[16]  P. Lips,et al.  Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. , 1991, The Journal of clinical endocrinology and metabolism.

[17]  S. Cummings,et al.  Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. , 1989, Archives of internal medicine.

[18]  L. Avioli,et al.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. , 1988, The Journal of clinical investigation.

[19]  P. Ross,et al.  Detection of prefracture spinal osteoporosis using bone mineral absorptiometry , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  D. Kiel,et al.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. , 1987, The New England journal of medicine.

[21]  C. Christiansen,et al.  Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. , 1987, The New England journal of medicine.

[22]  H. Genant,et al.  Long-term estrogen replacement therapy prevents bone loss and fractures. , 1985, Annals of internal medicine.

[23]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[24]  C. Chesnut,et al.  Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin. , 1981, Clinical chemistry.

[25]  N. Weiss,et al.  Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. , 1980, The New England journal of medicine.

[26]  S. Schwartz,et al.  Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  J. Stepan,et al.  Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. , 1987, Bone.

[28]  J. Lian,et al.  Osteocalcin: isolation, characterization, and detection. , 1984, Methods in enzymology.